DaVita Inc.
DVA
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and also includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Seeking Alpha • 4 days ago • DVA
DaVita: More Volatile But Better Upside Than Fresenius
Zacks Investment Research • 9 days ago • DVA
Why Is DaVita HealthCare (DVA) Up 1.1% Since Last Earnings Report?
Seeking Alpha • 20 days ago • DVA
DaVita Inc. (DVA) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript
PRNewsWire • 23 days ago • DVA
DaVita Inc. to Participate in Fireside Chat with Wolfe Research
PRNewsWire • about a month ago • DVA
DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.